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ABSTRACT 
Objective: The in silico free access web tools PASS online and ChemMapper were used to predict potential biological activities of compounds 1 to 8 
isolated from Maytenus gonoclada (Celastraceae). The constituents 4’-O-methylepigalocatequin (6), tingenone (7) and proanthocyanidin A (8), and 
ethanolic extracts were subjected to in vitro cytotoxicity using VERO cells and anti-Poliovirus assays.  
Methods: QSAR and molecular superposition, correlating the average number of pharmacophores were used in the prediction studies. Cellular line 
VERO ATCC CCL-81 was used to determine anti-Poliovirus effect, observed by colorimetric (MTT) method. The annexing V/propidium iodide assay 
was used to determine the occurrence of apoptosis in the cytotoxicity assays.  
Results: The experimental results found for constituents 6-8 were in accordance with observed data obtained through PASS online and 
ChemMapper simulation.  
Conclusion: Compound 7 showed higher cytotoxic and apoptosis induction properties, and 6 and 8 presented anti-Poliovirus activity. 
Keywords: Maytenus gonoclada, VERO cells Cytotoxicity, Anti-Poliovirus, Apoptosis, ChemMapper, PASS online. 
 
INTRODUCTION 
The use of natural products is widespread, mainly by people of less 
developed countries, to treat gastrointestinal problems, including 
ulcers, hepatic disorders, bacterial infections, and in the treatment of 
patients with viral infections [1-3]. In function of this antiviral 
potential, various natural compounds already registered focusing 
viral diseases such as influenza, herpes, hepatite and AIDS and 
others [4]. The main challenge of natural products researches 
involves high costs and a long time needed for larger scale 
evaluation of the pharmacological activity of isolated compounds. 
The majority of academic researches involving evaluation of 
biological effects is realized in small scale and in general is 
abandoned after work, without complete knowledgement about the 
real pharmacological potentials of the analyzed compounds. The 
large scale biological assays [High-throughput screening (HTS)] 
adopted by great pharmaceutical industries does not represent a 
feasible alternative in the university research centers due to the 
number of pure compounds needed, high cost and low yield of the 
process [5]. For enhance the efficacy of academic research and to 
provide an effective direction to the biological assays, in recent 
years, virtual screening has been applied to predict pharmacological 
effects of chemical compounds. These approaches performed on a 
computer (in silico) represent a new paradigm in the discovery and 
development of new bioactive compounds, both in academic as 
industrial level [6]. Furthermore, when studies of natural products 
are associated within silico evaluations a more appropriate targeting 
of biological tests are allowed, contributing to the process of drug 
discovery and making it more suitable for application of public 
financial support. 
The processes used in virtual screening can be complex and difficult 
to analyze. However, there are some accessible computational tools 
freely available through web servers that make more rapid and easy 
to do predictions about potential biological effects of chemical 
compounds. In general, the results are produced by methods that 
compare the structure of target compound with those available in 
databases of active compounds in biological assays realized in vitro 
and/or in vivo, new compounds in drug development pipeline, and 
drugs used in medicine and veterinary. The computer-aided 
predictions of several types of biological activity over the past 
decades have accelerated the early-stage pharmaceutical research 
[7]. Among the in silico programs used to predict potential biological 
activities PASS online and ChemMapper represent alternative tools.  
Through PASS (Prediction Activity Spectra of Substances) online tool 
are possible made predictions involving more than 3500 types of 
biological activities which includes adverse or toxical effects and 
action against virus, bacteria, fungi, protozoans, aquatic and 
terrestrial organisms related with environmental impacts, and other 
information. The results are produced based on quantitative 
structure–activity relationship (QSAR) models [8,9]. The 
ChemMapper tool [10] is based on SHAFTS (shape-feature 
similarity) software that was validating with the base data DUD-E 
(Directory of Useful Decoys) [7,11]. In ChemMapper tool is used the 
superposition of tridimensional (3D) chemical structures of 
compounds, together with the identification of a set of potential 
pharmacophores, to predict the potential biological effects of target 
compound [10,12,13]. 
Biological potentials of constituents isolated from M. gonoclada 
Until now, different biological properties have been associated to 
constituents isolated from species of the Celastraceae family, 
including some of the genera Maytenus. Species of this genus are 
distributed in tropical and sub-tropical regions, being Brazil 
considered as having the largest number of species. Among these 
species the most distinguished is M. ilicifolia, popularly known as 
“espinheira santa”, that is officially used as phytotherapeutic in 
Brazil for the treatment of gastrointestinal disorders [14].  
According with Haslam and coworkers [15] are attributed to species 
of Maytenus several pharmacological properties such as anti-
inflammatory, antiviral, bactericidal, anthelmintic, antiseptic and 
protector of the gastric mucosa. Furthermore, anti-protozoan [16] 
and antitumor [17,18] properties of some compounds isolated from 
Maytenus species reinforce the necessity of more detailed 
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pharmacological studies to establish the real potential of these 
compounds. 
The species Maytenus gonoclada Mart. (Celastraceae), popularly 
known as “tiuzinho” is naturally found in the state of Bahia, Minas 
Gerais and Rio de Janeiro, Brazil [19]. The pentacyclic triterpenes 
(TTPC) represent the principal group of secondary metabolites 
isolated from M. gonoclada, predominating compounds of the 
friedelane series [19] and a quinonemethide tingenone that has 
been found in more quantity in roots [20,21].  
Properties such as antitumor, antimicrobial, anti-malaria, cytotoxic 
and antiviral effects [22] were attributed to various TTPC. These 
properties make these terpenes candidates for new drugs [23]. To 
tingenone are attributed several biological activities, mainly 
associated to its cellular toxicity observed in vitro [24].  
The 4’-O-methylepigalocatequin and proanthocyanidins have 
received special attention as protective agents in the prevention of 
urinary tract infections and, due to its anti-oxidant property, also in 
the prevention of cardiovascular diseases [25]. Flavonoid 4’-O-
methylepigalocatequin was also observed to present anti-
inflammatory, immune-stimulant, anti-allergy and antiviral activities 
[26]. The triterpenes lupeol, α-amirin and β-amirin, commonly 
found in species of the Celastraceae family, present great potential 
for targeting cancer through various mechanisms such as the down 
regulation of transcription factors (e. g., nuclear factor-kappaB [NF-
κB]), anti-apoptotic proteins (e. g., bcl-2, bcl-xL) and promoters of 
cell proliferation (e. g., prostaglandin/cyclooxygenase-2 [COX-2]) 
[18].  
A large number of evidences confirm the role of inflammation in 
cancer development through mediators such as reactive oxygen 
species (ROS), free radicals, and inflammatory cytokines like tumor 
necrosis factor-α (TNFα), lymphotoxins, and angiogenic factors [18]. 
It was also described a stimulation of the apoptosis mechanism in 
cancer cells, that can be triggered by the activation of proteases such 
as caspase-3 and caspase-9, leading to the cells’ destruction [18]. 
In this work the constituents 3,7-dioxofriedelane (1), 3,16-dioxo-
12α-hydroxyfriedelane (2), 3,12-dioxofriedelane (3), friedelin (4), 
3-oxo-12α-hydroxyfriedelane (5), 4’-O-methylepigalocatechin (6), 
tingenone (7) and proanthocyanidin A (8) (Figure 1), isolated from 
M. gonoclada, were subjected to web tools PASS online and 
ChemMapper aiming to the prediction of their potential biological 
properties. Additionally, compounds 6, 7 and 8 and the ethanolic 
extracts from leaves, stems and roots of M. gonoclada were 
submitted to in vitro assays to determine the VERO cells cytotoxicity, 
apoptosis versus necrosis occurrence and anti-Poliovirus activity.  
MATERIAL AND METHODS 
Exploratory studies of potential biological activities 
The following in silico tools were used to predict potential biological 
activities for compounds 1 to 8 isolated from M. gonoclada.  
PASS online  
PASS online provides simultaneous predictions of several types of 
biological activities based on the chemical structures furnishing both 
the probabilities of each compound to be active (Pa) and inactive 
(Pi). Pa estimates the chance that the studied compound to belong to 
the sub-class of active compounds (resembles the structure of the 
molecules, which are the most typical in a sub-set of "actives" in 
PASS training set). Pi estimates the chance that the studied 
compound to belong to the sub-class of inactive compounds 
(resembles the structure of the molecules, which are the most 
typical in a sub-set of "inactives" in PASS training set). (http: 
//www. pharmaexpert. ru/passonline/index. php).  
To develop the study using PASS online firstly is necessary upload 
the chemical structure, saved in sdf file. The tool carries on the 
decomposition of the structure in the form of descriptors and 
compare with descriptors of biologically active compounds available 
in the database. Through QSAR models, each constituent of M. 
gonoclada was compared with more than 250,000 compounds, 
including drugs, drug candidates, compounds under register 
processes, toxic substances, oncogenes and other biologically active 
compounds [8,9]. At the end of analytical process the results were 
established by difference (Pa – Pi), and the potential biological 
activities generated for compounds 1 to 8 were organized in Table 1. 
 
 
Fig. 1: Chemical structures of compounds 1 to 8 isolated from M. 
gonoclada and subjected to in silico PASS online and Chem 
Mapper tools, to determine its potential biological effect. 
Compounds 6, 7 and 8 were submitted to in vitro anti-Poliovirus 
assays using VERO cells. 
 
Chem Mapper  
The ChemMapper tool (http: //lilab. ecust. edu. cn/chemmapper/ 
index. html) produces a number of possible tautomers together with 
protonation states to increase the extension of the search [10]. For 
most cases, this increased search extent, improves the accuracy of 
the final result [10,12,13]. To establish the potential biological 
activities of target compound is essential the acknowledgment of 
better chemical structure versus biological activity relationships 
profiles and the similarity of conformational superposition degrees. 
The similarity score suggested by this tool were converted in 
perceptual of similarity with the compounds of the database (1.2 
similarity score = 0.6 % similarity). The normalized values (score) 
presented by the tools were not used. The maximum values selected 
for the similarity score for the same target were considered only 
when > 60 % similarity. The profile of constituents 1 to 8 was 
analyzed both in terms of chemical structure, such as in relation to 
the type of molecule superposition, correlating the average number 
of pharmacophores found in each one, as well as the same function 
in terms of similarity of the spatial conformation. At the end of 
analytical process applied to compounds 1 to 8, the potential 
biological targets generated by this tool were organized in Table 2.  
Plant material 
M. gonoclada was collected in Serra da Piedade, Caeté, Minas Gerais, 
Brazil and identified by Dr. Rita Maria Carvalho-Okano, botanist of 
Universidade Federal de Viçosa, MG, Brazil. The voucher specimen 
(HBCB 60280) was deposited in the Herbarium of the Universidade 
Federal de Minas Gerais, BH, Minas Gerais, Brazil. Leaves, stems and 
roots were dried at room temperature and pulverized on a knife 
mill. Then, the powdered leaves and stems were respectively 
subjected to extraction in a Soxhlet apparatus using hexane, 
chloroform, ethyl acetate and ethanol. The powder of roots was 
extracted with hexane-ethyl ether (1:1), ethyl acetate and ethanol. 
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The extracting solvent was recovered using rotary evaporator at 
temperature < 55 °C. Through phytochemical methods, compounds 
1 to 8 (Figure 1) were previously isolated by [19,21]. In function of 
the water solubility, for the cytotoxicity and anti-Poliovirus in vitro 
assays, were selected the crude ethanolic extract from leaves 
(MGEEF), stems (MGEG) and roots (MGR) and constituents 6, 7 and 
8 (Figure 1).  
Preparation of chemical solutions 
Crude extracts MGEEF, MGEG and MGR, and constituents 6, 7 and 8 
were weighed into Eppendorf tubes and then dissolved in 
dimethylsulfoxide (DMSO) Merck, by means of ultrasound, for 10 
minutes, to obtain stock solution of 10.0 ± 2.0 mg/mL. Solutions of 
extracts MGEEF (12.4 mg/mL), MGEG (10.4 mg/mL) and MGR (10.4 
mg/mL) and of constituents 6 (12.5 mg/mL), 7 (10.5 mg/mL) and 8 
(11.2 mg/mL) were prepared. 
Cells, virus and stock solution  
Five passage adherent epithelial cells cultures of green monkey 
Cercopithecus aethiops (Cellular line VERO ATCC CCL-81), Poliovirus 
strain were kindly donated by Erna Geessien Kroon of Universidade 
Federal de Minas Gerais, Brazil and used for cytotoxicity and 
antiviral assays. Cells are prepared from healthy, confluent VERO 
cells that are maintained by passing every 5 ± 2 days, in Dulbecco 
modified eagle medium (DMEM Sigma-Aldrich®) supplemented with 
10 % fetal bovine serum (FBS, Sigma-Aldrich®), 50 mg/mL 
gentamicine, 100 U/mL penicillin and 5.0 µg/mL of amphotericin B. 
The culture was maintained at 37 °C in a humidified atmosphere 
containing 5 % CO2. Prior to the beginning of the trials, VERO cells 
were tested negative for mycoplasma [27]. The virus multiplication 
was conducted in monolayers of VERO cells. Stock viruses were 
prepared from supernatants of infected cells and stored at -70 °C. 
This cell line was chosen due to its known susceptibility to 
Poliovirus.  
Cytotoxicity evaluation 
Extracts and constituents of M. gonoclada were subjected to 
cytotoxicity assays aiming to establish a safe range concentration for 
further evaluation of anti-Poliovirus effect. VERO cells were treated 
with different concentrations of the ethanolic extract MGEEF, MGEG 
or MGR, and of constituents 6, 7 or 8 for 72h. After this incubation 
period, the cell viability was evaluated using the MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) tetrazolium 
reduction method [28]. Each sample was treated (in 3 replicas) with 
concentration varying from 0.30 to 125 µg/mL. The cytotoxicity was 
expressed as CC50 values (Concentration of sample that induces 50 
% inhibition of the cell growth).  
Viral titer 
The infectious titer of Poliovirus stock was determined through 
direct plate counting that is a method used to count the number of 
viable cells described by Burleson and coworkers [29]. VERO cells 
monolayers, previously growth in 6-well plate, were seeded at a 
density to yield 90-100 % confluence, about 2 days incubation in 
DMEM. Then the medium was discarded and replaced with DMEM 
with 200.0 µL of trypsin 10 μg/mL, without FBS and containing 
various 10-fold dilutions of Poliovirus in different well. A well 
containing the mock-infected cells was used as a control cell. After 
one hour of incubation, the inoculum was replaced with DMEM 
overlay containing 0.7 % agarose and 1.0 µg/mL of trypsin, followed 
by an incubation period of 3 days at 37 °C in a humidified 
atmosphere containing 5 % CO2. Then, the cells were fixed with 10 
% formaldehyde (v/v) for 60 minutes, washed with distilled water 
and stained with crystal violet an 10 % (m/v). Dilutions which 
showed 30-300 plaques were chosen for the calculation of virus titer 
using the formula: plaque forming units (PFU)/mL = n x 10i x CF, in 
which n = number of plates, CF = correction factor (1000/volume used 
for infect with Poliovirus), i = reciprocal of the dilution factor [30]. 
Anti-Poliovirus assay 
VERO cells were treated with trypsin 10 μg/mL and transferred to a 
96 well microplate (5x104 cells/well). For each ethanolic extract or 
compound 6, 7 or 8, were used four serial dilution (in 3 replicas). 
The Poliovirus suspensions were added to extracts, in four 
concentrations from CC50. During each assay, in parallels the 
following controls were used for cells (Not infected and untreated 
cells), cytotoxicity (Not infected cells treated with samples) and for 
Poliovirus (Infected untreated cells). The anti-Poliovirus activity was 
evaluated by colorimetric (MTT) method [31].  
The inhibition of Poliovirus replication was determined by the 
formula: % viral replication inhibition = (CVE-CV)/(C-CV). In this 
formula, V, CV, CC is equal to the average value of optical density at 
570 nm (DO570) observed for the well containing: cell + virus + 
extract (CVE), cell + virus (CV) and for the well with only cells (C). 
The concentration of sample effective for inhibit 50 % death of cells 
(EC50), observed in the assay CVE was established by linear 
regression considering adequate the values for R2 ≥ 0.90.  
Annexin V/propidium iodide apoptosis assay 
The annexin V/propidium iodide assay was used to determine the 
occurrence of apoptosis in the cytotoxicity assays. Initially, the 
annexin-V binding buffer 10x was diluted (1:10) in Milli-Q water. 
The VERO cells were washed 2x with FBS and re-suspended aiming 
to obtain 3 x 106 cells/mL in annexin binding buffer 1x (containing 
10 mM HEPES/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl2).  
In each assay tube were added 100.0 μL of the cell suspension, 5.0 
μL of anexin V FITC and 10.0 μL of propidium buffer. The tubes were 
incubated for 15 minutes at 25 oC, in the dark. Then, 400.0 μL anexin 
V binding buffer 1x/tube were added and analyzed, in at most 60 
minutes, using a Becton Dickinson FACSCalibur Flow Cytometer, 
with fluorescence FL1 at 414 nm and FL2 at 451 nm.  
 
Table 1: In silico test prediction of potential biologic effect using PASS online*tool 
Potential biological effect Constituents of M. gonoclada 
1 2 3 4 5 6 7 8 
Anti-inflammatory 0.82 0.68 0.68 0.77 0.76 0.53 0.79 0.33 
Antiulcerative 0.54 0.18 0.39 0.61 0.51 0.62 0.48 0.36 
Apoptosis agonist 0.87 0.72 0.82 0.87 0.81 0.72 0.87 0.62 
Bcl-xLinhibitor 0.06 ---- 0.06 0.08 0.05 ---- 0.10 ---- 
Bcl2 antagonist 0.02 ---- 0.02 0.09 0.02 ---- 0.23 ---- 
Topoisomerase II inhibitor ---- ---- ---- ---- ---- 0.29 ---- 0.26 
Transcription factor NF kappa B inhibitor 0.46 0.51 0.32 0.34 0.49 0.50 0.11 0.46 
Cytostatic ---- ---- ---- ---- ---- 0.56 0.04 0.41 
DNA polymerase I inhibitor ---- 0.12 ---- 0.02 0.18 0.31 0.11 0.24 
Antiviral ---- ---- ---- ---- ---- 0.32 ---- 0.25 
Antiviral (Hepatitis B) ---- ---- ---- ---- ---- 0.30 ---- 0.20 
Antiviral (Herpes) 0.31 0.41 0.36 0.39 0.42 0.43 0.30 0.38 
Antiviral (HIV) ---- ---- ---- ---- ---- 0.24 ---- 0.17 
Antiviral (Influenza) 0.58 0.44 0.58 0.70 0.67 0.65 0.64 0.52 
Antiviral (Rhinovirus) ---- 0.27 ---- ---- 0.32 0.48 0.07 0.40 
Viral entryinhibitor ---- ---- ---- 0.12 ---- 0.18 ---- ---- 
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*Values of difference Pa – Pi. (http: //www. pharmaexpert. ru/passonline), --- Not indicated or unsatisfactory. 
Table 2: In silico test prediction of potential biologic targets using Chem Mapper** tool 
Potential biological target Constituents of M. gonoclada 
1 2 3 4 5 6 7 8 
Androgen receptor 0.65 0.65 0.65 0.64 0.62 0.65 0.67 ---- 
Estrogen receptor 0.66 0.64 ---- 0.69 0.63 0.66 0.71 ---- 
Estrogen receptor β ---- ---- ---- 0.63 ---- 0.66 0.63 ---- 
Progesterone receptor 0.69 0.66 0.67 0.70 0.65 ---- 0.61 ---- 
Proto-oncogene serine/threonine-protein kinase Pim-1 ---- ---- ---- ---- ---- 0.74 ---- ---- 
Estradiol 17β-dehydrogenase 1 0.63 0.61 0.61 0.66 0.61 0.76 0.64 ---- 
Retinoic acid receptor RXR-α 0.63 0.61 0.62 0.65 0.61 ---- 0.62 ---- 
Phospholipase A2 ---- ---- ---- ---- ---- 0.78 ---- ---- 
Glutathione S-transferase a2 ---- ---- ---- 0.66 ---- ---- 0.66 ---- 
Glutathione S-transferase a3 ---- ---- ---- 0.66 ---- ---- 0.67 ---- 
Cell division protein kinase 6 ---- ---- ---- ---- ---- 0.62 ---- ---- 
Cell division protein kinase 2 ---- ---- ---- ---- ---- 0.65 ---- ---- 
Thymidylate synthase ---- ---- ---- ---- ---- 0.62 ---- ---- 
** http: //lilab. ecust. edu. cn/chemmapper/index. html., --- Not indicated or unsatisfactory. 
 
Cytotoxic effect based on percent cell viability of VERO cells in 
function of the treatment with ethanol extract from leaves (MGEEF), 
stems (MGEG) and roots (MGR) of M. gonoclada is showed in Figure 
2. The Poliovirus effects based on percent cell viability of VERO cells 
in function of the treatment with ethanol extracts are showed in 
Figure 3. The histograms obtained through the annexin 
V/propidium iodide assay related to apoptosis induced in VERO cells 
treated with compound 6, 7 and 8 are presented in Figure 4. The 
progression of apoptosis process of VERO cells associated to the 
concentration of compound 7, in Figure 5. 
Statistical analysis 
The median values ± standard deviation was representative of four 
independent in vitro assays. To establish CC50 and EC50 were used 
values of linear regression of concentrations associated to 
dose/response. The statistical analysis of data was realized using the 
software Prism 5.0, GraphPad Software Inc., San Diego, CA. 
RESULTS 
Through the analysis of data generated by the tool PASS online were 
found potential biological activities (Table 1) and by ChemMapper, 
the potential biological targets (Table 2) attributed for compounds 1 
to 8 (Figure 1). 
DISCUSSION 
Eight compounds isolated from M. gonoclada were subjected to the 
free web tools PASS online and ChemMapper to make predictions of 
their potential biological properties. The use of these tools is 
important as being a previously study aiming to establish adequate 
choice for in vitro or in vivo assays.  
The PASS online and ChemMapper tools were used in silico to make 
a prediction of potential biological activities (Table 1 and 2) of 
compounds 1 to 8 (Figure 1) isolated from M. gonoclada. The direct 
indication of potential biological activities, without mentioning the 
species of target virus was realized by comparison with the database 
of compounds with antiviral properties. A similar approach was 
adopted in the prediction of other biological effects (Table 1).  
For compound 6 and 7 was possible to infer the apoptosis inductor 
effect, observed by the prediction made by PASS online (Table 1). 
The suggestion of possible activities is important, because it opens 
perspectives for conducting studies aiming to identify the 
mechanisms of pro-apoptotic action involving the compounds 6 and 
7. The PASS online tool indicated potential antiviral activity against 
species of the virus influenza and Herpes (Table 1). Also indicate 
potential activity against DNA topoisomerase II, transcription factor 
NF kappa B inhibitor and DNA polymerase I (Table 1) that are 
important targets for researches of new substances with antiviral 
activity. DNA polymerase is considered as being a potential target 
associated to anti-Poliovirus activity [32]. The ChemMapper tool 
indicates potential inhibition properties of important antiviral 
targets, such as cell division protein kinase 2 and thymidylate 
synthase, attributed to compound 7 (Table 2). This tool does not 
provide potential biological targets for compound 8. According to 
Mitsuishi and coworkers [33] there are a relationship between 
phospholipase A2 activity and infection prevention with adenovirus. 
This can be suggestive of a potential anti-virus activity of compound 
6. 
Assenco and coworkers [24] reported the in vitro anti-Rotavirus 
(RV-SA11) effect induced by compounds 6, 7 and 8 (Figure 1), 
isolated from M. gonoclada. Thus, to continue the research related to 
pharmacological potential of substances isolated from M. gonoclada, 
in this work the ethanolic extracts and constituents 6, 7 and 8 were 
subjected to anti-Poliovirus in vitro assays. 
In general, the in vitro assays are based on the inhibition of viral 
cytopathic effect (CPE) in the cell cultures. In recent years, in the 
most widely used method the compound MTT is reduced to 
formazan by mitochondrial enzymes of cells that not suffer the CPE 
caused by viral infection. The assay is rapid, requires small amount 
of test sample and enables a direct assessment of cell viability [31]. 
Through the MTT method was quantified the cell viability of extracts 
MGEEF, MGEG and MGR, and of constituents 6, 7 and 8, using VERO 
cells and Poliovirus.  
Poliovirus is a human enterovirus of RNA genome, single positive 
strain, waterborne, transmitted from person to person through fecal 
excretion and oropharyngeal secretions, mainly oral fecal route. The 
receptor for Poliovirus is only expressed in human cells and some 
species of primates [34,35]. Part of the infection process occurs with 
the replication of virus in the gastrointestinal tract, causing viremia 
[36,37]. When the virus reaches the central nervous system it 
destroys motor nerves causing distinctive flaccid paralysis with 
permanent sensory loss [38]. The average incubation period of 
paralysis is approximately 10 days [39,40]. Only one in 150 primary 
polio infection causes paralysis, since most of them are subclinical 
infections [39]. Data inserted in Tables 1 and 2 indicate that 
compound 6 could be an antiviral candidate. None have been 
detected in PASS online and ChemMapper associated specifically to 
Poliovirus. Nevertheless, the relationship with phospholipase A2 
[41,42] is important for future studies related to anti-Poliovirus 
activity of compound 6. 
Apoptosis or programmed cell death is a physiological process 
which is essential for the elimination of modified cells, damaged or 
infected by a virus, for the removal of self-reactive lymphocytes, and 
to organize in developing tissues [43]. Apoptosis is morphologically 
characterized by condensation of nuclear chromatin, reduction in 
cell size, cytoplasm condensation, and loss of intercellular linkages 
and detachment of cells from the growth surface [44].  
The evaluation of apoptosis is important, since one of the main 
objectives of the current chemotherapy is the destruction of cells by 
inducing death through apoptosis and not by necrosis [45]. In the 
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case of cell death by necrosis, no programming occurs and the 
process is morphologically characterized by distinct mode of 
apoptosis. The necrosis is characterized by enlargement of the 
endoplasmic reticulum, mitochondria and other organelles, and 
consequently the cell. Subsequently, the cell membrane becomes 
permeable to molecules of high molecular weight, the chromatin 
suffer fragmentation, occur a dissolution of the nuclear membrane, 
resulting in cell disruption [46]. All compounds subjected to PASS 
online and ChemMapper in silico tools presented potential 
properties such as apoptosis agonist (Tables 1 and 2). The values of 
(Pa-Pi) ≥ 0.5 established by through PASS online indicate 
compounds 1 to 8 as being potential apoptosis agonists (Table 1) 
were herein considered important data associated to apoptosis. 
However, the values ≤ 0.5 attributed shows low probability of 
compounds 1 to 8 as regulator Bcl-xL inhibitor and Bcl-2 antagonist. 
All compounds presented potential activity as transcription factor 
NF kappa B inhibitors (Table 1).  Through ChemMapper tool were 
predicted for compounds 1 to 8 potential targets associated to 
apoptosis (Table 2) such as proto-oncogene serine/threonine-
protein kinase Pim-1 [47,48], Glutathione s-transferase [49], 
Androgen receptor [50], cytoplasmic phospholipase A2 [43], retinoic 
acid receptor RXR-alpha [51] and estrogen receptors [52,53]. 
According to Wong and coworkers [54], the induction of apoptosis 
represents good strategy in the cancer treatment.  In the in vitro 
labeling by annexin-v, this compound binds to the epithelial 
membrane of apoptotic cells that are in apoptosis process induced 
by treatment of cytotoxic substance. By the annexin V/propidium 
iodide assay is possible to quantify the initial and end populations of 
cells submitted to apoptosis process.  
The ethanolic extract MGEEF, MGEG and MGR, and constituents 6, 7 
and 8 (Figure 1) were subjected to cytotoxic assays using VERO cells and 
subsequent assay against Poliovirus. The value of CC50, with 95 % 
confidence interval was determined for MGEEF (87.74 to 119.30 
µg/mL), MGR (71.71 to 95.01 µg/mL) and MGEG (158.9 to 212.9 


















Fig. 2: Cytotoxic effect based on percent cell viability of VERO cells in function of the treatment with ethanol extract from leaves (MGEEF), 
stems (MGEG) and roots (MGR) of M. gonoclada determined through optical density at 570 nm (DO570). (DO570 of treated cells ÷ DO570 of 
control cells) × 100. Each point corresponds to the median of each value of serial dilution. 
 
In the assays conditions, the extracts showed no anti-Poliovirus 
effect, or if it is present, it was herein considered insufficient to 
offset the cytotoxic effects generated (Figure 3). Compounds 6 and 8 
showed anti-Poliovirus properties. 
 
 
Fig. 3: Poliovirus effect based on percent cell viability of VERO 
cells in function of the treatment with ethanol extract from 
leaves (MGEEF), stems (MGEG) and roots (MGR) of M. gonoclada 
against determined through optical density at 570 nm (DO570). 
[(DO570 of treated cells - DO570 of virus control) ÷ DO570 of 
control cells) × 100. Each point corresponds to the median of 
each value of serial dilution. 
Cytotoxicity in vivo is a complex event, whose expression is 
manifested through a wide spectrum of effects, ranging from 
functional or metabolic aberrations and complex morphological 
changes, depending on which no cell death or cell death is observed. 
Based on the study, the definitions of cytotoxicity vary considering if 
cells are death or simply have altered metabolism [55]. The in vitro 
assays using cell culture are useful and necessary to define the basal 
cytotoxicity, i. e., a compound that has the property of inducing 
damage to essential functions of the cell or even cell death. Cytotoxic 
assays are important to establish the maximum concentration used, 
for subsequent antiviral activity evaluation [56]. Smaller percentage 
of surviving cells indicates greater cytotoxic potential of the tested 
sample. If the cell viability was reduced to 50 % in wells containing 
only cells, the sample has a median cytotoxic potential CC50 [57]. 
According to Rieser and coworkers [58], extracts and compounds 
that shown values of CC50 ≤ 20.0 µg/mL or 4.0 µg/mL, respectively, 
are considered cytotoxic.  
According to Vasilevsky and coworkers [59] plant-derived of 
pentacyclic triterpenes provide a versatile structural platform for 
the discovery of new biologically active compounds. In the present 
study tingenone (7) (Figure 1) was considered the more cytotoxic 
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constituent evaluated (Figure 2). For this reason, terpene 7 was 
submitted to annexin V/propidium iodide assay to verify if the cell 
death was induced by apoptosis process, or not. The percent of 
viable cells and apoptotic cells was determined by flux cytometry. 
 
Compound 6: 125.0 µg/mL 
Necrosis (Q1): 4.0% 
Apoptosis (Q2+Q3): 67.7% 
Viable cells: 28.3% 
 
Compound 6: 15.6 µg/mL 
Necrosis (Q1): 1.6% 
Apoptosis (Q2+Q3): 33.1% 
Viable cells: 65.2% 
 
Compound 7: 17.5 µg/mL 
Necrosis (Q1): 7.5% 
Apoptosis (Q2+Q3): 76.9% 
Viable cells (Q4): 15.6% 
 
Compound 7: 4.3 µg/mL 
Necrosis (Q1): 9.8% 
Apoptosis (Q2+Q3): 77.1% 
Viable cells (Q4): 12.8% 
 
 
Compound 8: 15.0 µg/mL 
Necrosis (Q1): 5.7% 
Apoptosis (Q2+Q3): 50.4% 
Viable cells (Q4): 43.9% 
 
Compound 8: 15.0 µg/mL 
Necrosis (Q1): 3.7% 
Apoptosis (Q2+Q3): 45.2% 
Viable cells (Q4): 51.0% 
Fig. 4: Histograms obtained from the annexin V/propidium iodide assay used to determine apoptosis induced in VERO cells treated with 
4’-O-methylepigalocatequin (6), tingenone (7) and proanthocyanidin A (8). Fluorescence FL1 at 414 nm and FL2 at 451 nm. In the lower 
left quadrant of hystogram is shown the incidence of viable cells (annexin V-/PI-), in the lower right quadrant, the incidence of early or 
initial apoptosis (annexin V+/PI-), in the upper right quadrant, cells in late apoptosis or secondary necrosis (annexin V+/PI+), and in the 
upper left quadrant necrotic cells (annexin V-/PI+). 
 
In the lower left quadrant of the cytogram obtained (Figure 4) is 
shown the incidence of viable cells (annexin V-/PI-), in the lower 
right quadrant, the incidence of early or initial apoptosis (annexin 
V+/PI-), in the upper right quadrant, cells in late apoptosis or 
secondary necrosis (Annexin V+/PI+), and in the upper left quadrant 
necrotic cells (annexin V-/PI+). This assay was useful to determine 
that terpene 7 induces cellular death by apoptosis, confirming the 
predictions made using PASS online and ChemMapper. The late 
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apoptose represent the principal event observed in progression of 
apoptosis process of VERO cells induced by compound 7. Even in 
low concentration (4.34 µg/mL) the apoptose rate was considered 
as important when compared to viable cells (Figure 5). 
 
Fig. 5: Progression of apoptosis process of VERO cells associated 
to the concentration of tingenone (7). 
 
CONCLUSION 
By the results was possible to conclude for compound 7 a higher 
cytotoxic and apoptosis inductor properties in VERO cells, and 
constituent 6 and 8 showed anti-Poliovirus activity. These results 
were observed by the prediction made through PASS online and 
ChemMapper and by the in vitro assays.  
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